Recursion Pharmaceuticals
RXRX
#4161
Rank
S$2.80 B
Marketcap
$6.97
Share price
1.84%
Change (1 day)
-45.02%
Change (1 year)

Revenue for Recursion Pharmaceuticals (RXRX)

Revenue in 2024 (TTM): S$77.27 Million

According to Recursion Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is S$78.54 Million. an increase over the revenue in the year 2023 that were of S$57.94 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Recursion Pharmaceuticals from 2020 to 2024

Annual revenue

Year Revenue Change
2024 S$79.5 M37.2%
2023 S$57.94 M8.93%
2022 S$53.19 M293.49%
2021 S$13.51 M199.41%
2020 S$4.51 M